Paxton AI Review: Is a $499 Seat Worth It for a Small Firm?

Paxton AI costs 499 dollars per user per month, or 2,999 per user per year, which makes it the most expensive published rate in legal AI. It is worth it for a personal injury firm that burns real hours building medical chronologies, because that is the job the price is built around. It is a substantial overpay for a lawyer who mainly needs to find the on-point case, and the annual plan is genuinely half the monthly one, so anyone who buys monthly is paying a large premium for the right to cancel.

Most reviews of legal AI tools grade features. That is the wrong test, because every product in this category now claims research, drafting and document analysis, and the feature lists have converged to the point of being useless for deciding anything. The useful question is narrower: what specific piece of work does this seat take off your desk, and is that piece of work expensive enough in your practice to justify the number?

For Paxton the answer is unusually clear, and it is not the research.

We keep the full pricing evidence, the source for every figure, and the comparison against the rest of the market on our Paxton AI pricing page. This piece is the narrower question: for a firm of one to ten lawyers, does the seat earn out?

What Paxton actually charges

Two plans, read directly from the vendor pricing page on 9 September 2026. Individual is 499 dollars per user per month, or 2,999 per user per year on annual billing. Enterprise is custom and volume-based, with firm-wide access, administrative controls and an account manager. There is a seven day trial you can start without talking to anyone.

Worth flagging before you budget: several comparison sites currently ranking on the first page of Google describe a Paxton "Pro" plan at 199 dollars and a "Premium" plan at 299. Neither tier exists. The published lineup is Individual and Enterprise, and the Individual rate is 499. We are not suggesting anyone published those figures in bad faith, since prices move and directory pages go stale, but a firm budgeting three seats from the 199 figure would be out by more than ten thousand dollars a year.

The thing that genuinely surprised us is the annual discount. Most software vendors take ten to twenty percent off an annual commitment. Paxton takes off half: 499 times twelve is 5,988, and the annual plan is 2,999. Read in the other direction, monthly billing costs you the price of a second seat in exchange for flexibility. If you have run the trial and you are reasonably confident, the annual rate is the real price and the monthly figure is a convenience premium.

The feature that explains the price

Paxton builds medical chronologies and medical billing summaries. Feed it a medical record set and it produces a dated treatment timeline; feed it the billing and it produces a structured summary of what was charged across that history. Its own navigation leads with personal injury among the five practice areas it targets, and that ordering is not an accident.

Chronology building is the most tedious, most delegated, most hour-consuming task in plaintiff practice. A thousand page record set can absorb two days of paralegal time before anyone has formed a view about the case. It is also, structurally, exactly the kind of problem these models handle well: extraction and ordering from a large volume of semi-structured text, where a human then verifies rather than authors.

Once you see that, the 499 stops looking strange. Read Paxton as a personal injury tool that also does legal research, rather than a legal research tool that inexplicably costs 499 dollars, and the pricing is coherent. It also explains something most competitors do not bother with: Paxton publishes adherence to HIPAA alongside SOC 2 and ISO 27001. Legal research vendors generally do not claim HIPAA, because they never touch protected health information. A tool designed to ingest medical records has to.

Does it earn out? The honest arithmetic

The vendor version of this math is that if you bill 350 an hour and the tool saves you eight hours a month, you have recovered 2,800 dollars against a 499 dollar cost and the case closes itself. That math is too generous, and firms who have run it honestly know why.

Saved hours are only worth money if they turn into billed hours. For a firm whose constraint is a full calendar, recaptured time converts almost directly into revenue. For a firm whose constraint is a thin pipeline, the saved hours convert into a shorter workday, which is genuinely valuable but does not appear in the operating account. Vendors price against the first firm and sell to both.

Personal injury is the case where the math works cleanly, and for an unusual reason: contingency practice means the time was never billable in the first place, so the saving is pure margin rather than recaptured billing. Two paralegal days per case, across even a modest caseload, dwarfs 2,999 a year. If chronology work is a routine part of your file load, this is one of the few legal AI purchases where the arithmetic is not a stretch.

There is a caveat specific to plaintiff practice that is worth saying plainly, because it cuts against the purchase. In personal injury the binding constraint is usually not back-office throughput, it is intake. The firm that answers the call first signs the case, and a chronology tool does nothing about a missed call at seven in the evening. If your signed-case rate is limited by how many enquiries reach a human, making sure an after-hours intake call actually gets answered will move revenue further than any research seat will. Fix the front door before you optimize the back office.

Where Paxton is the wrong purchase

Three situations come up repeatedly.

The first, and by far the most common, is the lawyer who wants to find the on-point case. If your week is research and reading rather than record review, you are paying for medical chronologies, billing summaries, drafting and document analysis in order to use a search box. This is the single most reliable way money gets wasted in this category, and it is not specific to Paxton. Focused case law search is the cheap layer of this market and it stays cheap.

The second is the firm choosing between Paxton and a traditional research subscription on price alone. Westlaw Advantage publishes 256.75 dollars per user per month for single-circuit coverage and 399.75 for all states plus federal, both of which undercut Paxton monthly, and Westlaw brings KeyCite. Paxton closes most of that gap on annual billing at an effective 249.92 a month. But they are not the same purchase, and treating them as interchangeable line items produces a bad decision in either direction. We lay the whole field out side by side on our legal research pricing comparison.

The third is any firm that has not checked its bar benefit. A large number of US state bars include Fastcase or vLex library access in annual dues. That benefit generally covers the library rather than the AI on top of it, which is the most common misunderstanding we see, but it does mean your baseline research cost may already be zero. That changes what any seat is actually buying you.

What Paxton does not do

It does not publish a citator, and neither do we, so this is an observation rather than a dig. Paxton finds and analyzes authority across all fifty states plus federal material. What it does not offer is the check Westlaw means by KeyCite and Lexis means by Shepard's: a systematic answer to whether a case has been overruled, distinguished or criticized, in the form a court expects you to have run.

This matters more every quarter. Damien Charlotin's database of court decisions involving AI-hallucinated citations recorded 2,035 cases as of 9 September 2026, up from 719 in January. Reading the US federal sanctions decisions from 2026, the pattern is consistent and it is not what people assume: none of them sanctioned a lawyer for using AI. They sanctioned filings nobody read, and the variable separating a public reprimand from a five-figure award was what counsel did once the problem surfaced. Under ABA Formal Opinion 512, issued 29 July 2024, the verification duty stays with you regardless of which tool produced the draft.

Every vendor in this market, Paxton included, links its citations to primary sources. That is the right design and it makes verification fast. It does not make verification optional. A citation that resolves to a dead page is not verified, it is unverifiable, which stopped being hypothetical the day every Casetext permalink began returning a 410.

The verdict

Buy it if you run plaintiff-side personal injury work with real medical records, and buy the annual plan, because the monthly rate is double for no benefit you are likely to use. The chronology and billing summary features are a genuine differentiator rather than a repackaged chatbot, the HIPAA posture is the right one for the data involved, and the seat can earn out on a single case.

Do not buy it as a research subscription. At 499 a month it is the most expensive published seat in legal AI, and the premium is entirely in features a research-first practice will not open. If what you actually need is to ask a legal question and read the decisions that answer it, that costs a small fraction of this, and we set out the direct comparison on our Paxton AI alternative page.

One structural point in Paxton's favor deserves credit regardless of fit. You can read its price, compare it and budget against it today, without a discovery call and without a directory guessing on your behalf. Harvey, Legora, vLex and LexisNexis will all make you book a meeting before you learn a number. In a market this opaque, publishing the rate is worth something, even when the rate is high.